These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20485497)

  • 1. Antiretroviral treatment start-time during primary SIV(mac) infection in macaques exerts a different impact on early viral replication and dissemination.
    Sellier P; Mannioui A; Bourry O; Dereuddre-Bosquet N; Delache B; Brochard P; Calvo J; Prévot S; Roques P
    PLoS One; 2010 May; 5(5):e10570. PubMed ID: 20485497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resting CD4+ T lymphocytes but not thymocytes provide a latent viral reservoir in a simian immunodeficiency virus-Macaca nemestrina model of human immunodeficiency virus type 1-infected patients on highly active antiretroviral therapy.
    Shen A; Zink MC; Mankowski JL; Chadwick K; Margolick JB; Carruth LM; Li M; Clements JE; Siliciano RF
    J Virol; 2003 Apr; 77(8):4938-49. PubMed ID: 12663799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of viral replication in blood and lymphoid tissues during SIVmac251 infection of macaques.
    Mannioui A; Bourry O; Sellier P; Delache B; Brochard P; Andrieu T; Vaslin B; Karlsson I; Roques P; Le Grand R
    Retrovirology; 2009 Nov; 6():106. PubMed ID: 19930655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simian Immunodeficiency Virus Persistence in Cellular and Anatomic Reservoirs in Antiretroviral Therapy-Suppressed Infant Rhesus Macaques.
    Mavigner M; Habib J; Deleage C; Rosen E; Mattingly C; Bricker K; Kashuba A; Amblard F; Schinazi RF; Lawson B; Vanderford TH; Jean S; Cohen J; McGary C; Paiardini M; Wood MP; Sodora DL; Silvestri G; Estes J; Chahroudi A
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29997216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir.
    Avalos CR; Abreu CM; Queen SE; Li M; Price S; Shirk EN; Engle EL; Forsyth E; Bullock BT; Mac Gabhann F; Wietgrefe SW; Haase AT; Zink MC; Mankowski JL; Clements JE; Gama L
    mBio; 2017 Aug; 8(4):. PubMed ID: 28811349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the Intactness of Persistent Viral Genomes in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Initiating Antiretroviral Therapy within One Year of Infection.
    Long S; Fennessey CM; Newman L; Reid C; O'Brien SP; Li Y; Del Prete GQ; Lifson JD; Gorelick RJ; Keele BF
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virologic and Immunologic Features of Simian Immunodeficiency Virus Control Post-ART Interruption in Rhesus Macaques.
    Strongin Z; Micci L; Fromentin R; Harper J; McBrien J; Ryan E; Shenvi N; Easley K; Chomont N; Silvestri G; Paiardini M
    J Virol; 2020 Jul; 94(14):. PubMed ID: 32350073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of early anti-retroviral therapy on the pathogenic changes in mucosal tissues of SIV infected rhesus macaques.
    Malzahn J; Shen C; Caruso L; Ghosh P; Sankapal SR; Barratt-Boyes S; Gupta P; Chen Y
    Virol J; 2012 Nov; 9():269. PubMed ID: 23150992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Proviral DNA in Circulating Cells Correlates with Plasma Viral Rebound in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Antiretroviral Therapy Interruption.
    Ziani W; Shao J; Wang X; Russell-Lodrigue K; Liu YZ; Montaner LJ; Veazey RS; Xu H
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33408173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain macrophages harbor latent, infectious simian immunodeficiency virus.
    Abreu C; Shirk EN; Queen SE; Beck SE; Mangus LM; Pate KAM; Mankowski JL; Gama L; Clements JE
    AIDS; 2019 Dec; 33 Suppl 2(Suppl 2):S181-S188. PubMed ID: 31789817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initiation of HAART during acute simian immunodeficiency virus infection rapidly controls virus replication in the CNS by enhancing immune activity and preserving protective immune responses.
    Graham DR; Gama L; Queen SE; Li M; Brice AK; Kelly KM; Mankowski JL; Clements JE; Zink MC
    J Neurovirol; 2011 Feb; 17(1):120-30. PubMed ID: 21165785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. nef gene is required for robust productive infection by simian immunodeficiency virus of T-cell-rich paracortex in lymph nodes.
    Sugimoto C; Tadakuma K; Otani I; Moritoyo T; Akari H; Ono F; Yoshikawa Y; Sata T; Izumo S; Mori K
    J Virol; 2003 Apr; 77(7):4169-80. PubMed ID: 12634375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-resident macrophages can contain replication-competent virus in antiretroviral-naive, SIV-infected Asian macaques.
    DiNapoli SR; Ortiz AM; Wu F; Matsuda K; Twigg HL; Hirsch VM; Knox K; Brenchley JM
    JCI Insight; 2017 Feb; 2(4):e91214. PubMed ID: 28239657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Antiretroviral Therapy Prevents Viral Infection of Monocytes and Inflammation in Simian Immunodeficiency Virus-Infected Rhesus Macaques.
    Rabezanahary H; Clain J; Racine G; Andreani G; Benmadid-Laktout G; Borde C; Mammano F; Mesplèdes T; Ancuta P; Zghidi-Abouzid O; Estaquier J
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32907978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious Virus Persists in CD4
    Abreu CM; Veenhuis RT; Avalos CR; Graham S; Queen SE; Shirk EN; Bullock BT; Li M; Metcalf Pate KA; Beck SE; Mangus LM; Mankowski JL; Clements JE; Gama L
    J Virol; 2019 Aug; 93(15):. PubMed ID: 31118264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-Term Pegylated Interferon α2a Treatment Does Not Significantly Reduce the Viral Reservoir of Simian Immunodeficiency Virus-Infected, Antiretroviral Therapy-Treated Rhesus Macaques.
    Palesch D; Bosinger SE; Mavigner M; Billingsley JM; Mattingly C; Carnathan DG; Paiardini M; Chahroudi A; Vanderford TH; Silvestri G
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29720521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses.
    Mueller YM; Do DH; Altork SR; Artlett CM; Gracely EJ; Katsetos CD; Legido A; Villinger F; Altman JD; Brown CR; Lewis MG; Katsikis PD
    J Immunol; 2008 Jan; 180(1):350-60. PubMed ID: 18097036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral therapy during primary simian immunodeficiency virus infection fails to prevent acute loss of CD4+ T cells in gut mucosa but enhances their rapid restoration through central memory T cells.
    Verhoeven D; Sankaran S; Silvey M; Dandekar S
    J Virol; 2008 Apr; 82(8):4016-27. PubMed ID: 18272585
    [